Iontophoresis for the cutaneous delivery of nanoentraped drugs

References

• Anselmo AC, Mitragotri S. An overview of clinical and commercial impact of drug delivery systems. J Controlled Release. 2014;190:15–28.
   PubMed Web of Science ®Google Scholar
• Ghosn J, Taiwo B, Seedat S, et al. Hiv. Lancet. 2018;392:685–697.
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26:1261–1268.
   PubMed Web of Science ®Google Scholar
• Liu X, Testa B, Fahr A. Lipophilicity and its relationship with passive drug permeation. Pharm Res. 2010;28:962–977.
   PubMed Web of Science ®Google Scholar
• Naik A, Kalia YN, Guy RH. Transdermal drug delivery: overcoming the skin’s barrier function. Pharm Sci Technol Today. 2000;3:318–326.
   PubMedGoogle Scholar
• Gratieri T, Santer V, Kalia YN. Basic principles and current status of transcorneal and transscleral iontophoresis. Expert Opin Drug Deliv. 2016;14:1091–1102.
   PubMed Web of Science ®Google Scholar
• Kalia YN, Naik A, Garrison J, et al. Iontophoretic drug delivery. Adv Drug Deliv Rev. 2004;56:619–658. DOI:10.1016/j.addr.2003.10.026
   PubMed Web of Science ®Google Scholar
• Gratieri T, Kalia YN. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier. Adv Drug Deliv Rev. 2013;65:315–329. DOI:10.1016/j.addr.2012.04.012
   PubMed Web of Science ®Google Scholar
• Cázares-Delgadillo J, Ganem-Rondero A, Merino V, et al. Controlled transdermal iontophoresis for poly-pharmacotherapy: simultaneous delivery of granisetron, metoclopramide and dexamethasone sodium phosphate in vitro and in vivo. Eur J Pharm Sci. 2016;85:31–38.
   PubMed Web of Science ®Google Scholar
• Santer V, Del Río Sancho S, Lapteva M, et al. Targeted intracorneal delivery—Biodistribution of triamcinolone acetonide following topical iontophoresis of cationic amino acid ester prodrugs. Int J Pharm. 2017;525:43–53.
   PubMedGoogle Scholar
• Singhal M, Serna C, Merino V, et al. Current profile controlled transdermal delivery of pramipexole from an iontophoretic patch system in vitro and in vivo. Eur J Pharm Biopharm. 2021;166:175–181.
   PubMed Web of Science ®Google Scholar
• Singhal M, Serna C, Kalaria D, et al. Effect of continuous and multi-phasic current profiles on the iontophoretic transport of pramipexole, rasagiline and huperzine A: depicting temporal variation and biodistribution in the skin. Int J Pharm. 2021;599:120445.
   PubMedGoogle Scholar
• Lapteva M, Sallam MA, Goyon A, et al. Non-invasive targeted iontophoretic delivery of cetuximab to skin. Expert Opin Drug Deliv. 2020;17:589–602.
   PubMed Web of Science ®Google Scholar
• Gelfuso GM, Figueiredo FV, Gratieri T, et al. The effects of pH and ionic strength on Topical Delivery of a Negatively Charged Porphyrin (TPPS4). J Pharm Sci. 2008;97:4249–4257.
   PubMed Web of Science ®Google Scholar
• Kalaria DR, Singhal M, Patravale V, et al. Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: transdermal polypharmacy to treat Parkinson’s disease. Eur J Pharm Biopharm. 2018;127:204–212.
   PubMed Web of Science ®Google Scholar
• Singhal M, Merino V, Rosini M, et al. Controlled iontophoretic delivery in vitro and in vivo of ARN14140—A multitarget compound for alzheimer’s disease. Mol Pharm. 2019;16:3460–3468.
   PubMedGoogle Scholar
• Abla N, Naik A, Guy RH, et al. Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery. Pharm Res. 2006;23:1842–1849.
   PubMed Web of Science ®Google Scholar
• Abla N, Naik A, Guy RH, et al. Effect of charge and molecular weight on transdermal peptide delivery by iontophoresis. Pharm Res. 2005;22:2069–2078.
   PubMed Web of Science ®Google Scholar
• Del Río-Sancho S, Cros C, Coutaz B, et al. Cutaneous iontophoresis of μ-conotoxin CnIIIC—A potent Na V 1.4 antagonist with analgesic, anaesthetic and myorelaxant properties. Int J Pharm. 2017;518:59–65.
   PubMedGoogle Scholar
• Krishnan G, Roberts MS, Grice J, et al. Iontophoretic skin permeation of peptides: an investigation into the influence of molecular properties, iontophoretic conditions and formulation parameters. Drug Deliv Transl Res. 2014;4:222–232.
   PubMed Web of Science ®Google Scholar
• Dubey S, Perozzo R, Scapozza L, et al. Noninvasive transdermal iontophoretic delivery of biologically active human basic fibroblast growth factor. Mol Pharm. 2011;8:1322–1331.
   PubMed Web of Science ®Google Scholar
• Darade AR, Lapteva M, Hoffmann T, et al. Effect of mRNA delivery modality and formulation on cutaneous mRNA distribution and downstream eGFP expression. Pharmaceutics. 2022;14:151.
   PubMed Web of Science ®Google Scholar
• Cázares-Delgadillo J, Naik A, Ganem-Rondero A, et al. Transdermal delivery of cytochrome C—A 12.4 kDa protein—Across intact skin by constant–Current iontophoresis. Pharm Res. 2007;24:1360–1368.
   PubMed Web of Science ®Google Scholar
• Dubey S, Kalia YN. Electrically-assisted delivery of an anionic protein across intact skin: cathodal iontophoresis of biologically active ribonuclease T1. J Controlled Release. 2011;152:356–362.
   PubMed Web of Science ®Google Scholar
• Dubey S, Kalia YN. Non-invasive iontophoretic delivery of enzymatically active ribonuclease a (13.6kDa) across intact porcine and human skins. J Controlled Release. 2010;145:203–209.
   PubMed Web of Science ®Google Scholar
• Gelfuso GM, Gratieri T, Delgado-Charro MB, et al. Iontophoresis-targeted, follicular delivery of minoxidil sulfate for the treatment of alopecia. J Pharm Sci. 2013;102:1488–1494.
   PubMed Web of Science ®Google Scholar
• Turner NG, Guy RH. Visualization and quantitation of iontophoretic pathways using confocal microscopy. J Investig Dermatol Symp Proc. 1998;3:136–142.
   PubMedGoogle Scholar
• Cullander C, Guy RH. Sites of iontophoretic current flow into the skin: identification and characterization with the vibrating probe electrode. J Invest Dermatol. 1991;97:55–64.
   PubMed Web of Science ®Google Scholar
• Kajimoto K, Yamamoto M, Watanabe M, et al. Noninvasive and persistent transfollicular drug delivery system using a combination of liposomes and iontophoresis. Int J Pharm. 2011;403:57–65.
   PubMed Web of Science ®Google Scholar
• Quintão WD, Alencar-Silva T, de Fátima Borin M, et al. Microemulsions incorporating brosimum gaudichaudii extracts as a topical treatment for vitiligo: in vitro stimulation of melanocyte migration and pigmentation. J Mol Liq. 2019;294:111685.
   Web of Science ®Google Scholar
• Patzelt A, Lademann J. Recent advances in follicular drug delivery of nanoparticles. Expert Opin Drug Deliv. 2020;17:49–60.
   PubMed Web of Science ®Google Scholar
• Goyal R, Macri LK, Kaplan HM, et al. Nanoparticles and nanofibers for topical drug delivery. J Controlled Release. 2016;240:77–92.
   PubMed Web of Science ®Google Scholar
• Lima AL, Gratieri T, Cunha-Filho M, et al. Polymeric nanocapsules: a review on design and production methods for pharmaceutical purpose. Methods. 2022;199:54–66.
   PubMed Web of Science ®Google Scholar
• Ferreira-Nunes R, de Silva SMM, de Souza PEN, et al. Incorporation of Eugenia dysenterica extract in microemulsions preserves stability, antioxidant effect and provides enhanced cutaneous permeation. J Mol Liq. 2018;265:408–415.
   Web of Science ®Google Scholar
• Kazemi M, Mombeiny R, Tavakol S, et al. A combination therapy of nanoethosomal piroxicam formulation along with iontophoresis as an anti‐inflammatory transdermal delivery system for wound healing. Int Wound J. 2019;16:1144–1152.
   PubMed Web of Science ®Google Scholar
• Mombeiny R, Tavakol S, Kazemi M, et al. Anti‐inflammatory ethosomal nanoformulation in combination with iontophoresis in chronic wound healing: an ex vivo study. IET Nanobiotechnol. 2021;15:710–718.
   PubMed Web of Science ®Google Scholar
• Aguilella V, Kontturi K, Murtomäki L, et al. Estimation of the pore size and charge density in human cadaver skin. J Controlled Release. 1994;32:249–257.
   Web of Science ®Google Scholar
• Lademann J, Patzelt A, Richter H, et al. Determination of the cuticula thickness of human and porcine hairs and their potential influence on the penetration of nanoparticles into the hair follicles. J Biomed Opt. ∙∙ A study determining the optimal nanoparticle size for penetration into hair follicles 2009;14:021014.doi: 10.1117/1.3078813
   PubMed Web of Science ®Google Scholar
• Matos BN, Reis TA, Gratieri T, et al. Chitosan nanoparticles for targeting and sustaining minoxidil sulphate delivery to hair follicles. Int j biol macromol. 2015;75:225–229.
   PubMed Web of Science ®Google Scholar
• Santos GA, Angelo T, Andrade LM, et al. The role of formulation and follicular pathway in voriconazole cutaneous delivery from liposomes and nanostructured lipid carriers. Colloids Surf B Biointerfaces. 2018;170:341–346.
   PubMed Web of Science ®Google Scholar
• Pires FQ, da Silva JKR, Sa-Barreto LL, et al. Lipid nanoparticles as carriers of cyclodextrin inclusion complexes: a promising approach for cutaneous delivery of a volatile essential oil. Colloids Surf B Biointerfaces. 2019;182:110382.
   PubMed Web of Science ®Google Scholar
• Ushirobira CY, Afiune LAF, Pereira MN, et al. Dutasteride nanocapsules for hair follicle targeting: effect of chitosan-coating and physical stimulus. Int j biol macromol. 2020;151:56–61.
   PubMed Web of Science ®Google Scholar
• Ferreira-Nunes R, Cunha-Filho M, Gratieri T, et al. Follicular-targeted delivery of spironolactone provided by polymeric nanoparticles. Colloids Surf B Biointerfaces. 2021;208:112101.
   PubMed Web of Science ®Google Scholar
• Tolentino S, Pereira MN, de Sousa MC, et al. The influence of sebaceous content on the performance of nanosystems designed for the treatment of follicular diseases. J Drug Deliv Sci Technol. 2020;59:101895. DOI:10.1016/j.jddst.2020.101895
   Web of Science ®Google Scholar
• Angelo T, El-Sayed N, Jurisic M, et al. Effect of physical stimuli on hair follicle deposition of clobetasol-loaded lipid nanocarriers. Sci Rep. 2020;10:176.
   PubMed Web of Science ®Google Scholar
• Gao Y, Du L, Li Q, et al. How physical techniques improve the transdermal permeation of therapeutics: a review. Medicine (Baltimore). 2022;101:e29314.
   PubMed Web of Science ®Google Scholar
• Nawrocki S, Cha J. The etiology, diagnosis, and management of hyperhidrosis: a comprehensive review. J Am Acad Dermatol. 2019;81:669–680.
   PubMed Web of Science ®Google Scholar
• Pariser DM, Ballard A. Iontophoresis for palmar and plantar hyperhidrosis. Dermatol Clin. 2014;32:491–494.
   PubMed Web of Science ®Google Scholar
• McConaghy JR, Fosselman D. Hyperhidrosis: management options. Am Fam Physician. 2018;97:729–734.
   PubMed Web of Science ®Google Scholar
• Serrano-Castañeda P, Escobar-Chavez JJ, Rodriguez-Cruz IM, et al. Microneedles as enhancer of drug absorption through the skin and applications in medicine and cosmetology. J Pharm Pharm Sci. 2018;21:73–93.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yu J, Kahkoska AR, et al. Advances in transdermal insulin delivery. Adv Drug Deliv Rev. 2019;139:51–70.
   PubMed Web of Science ®Google Scholar
• Curdy C, Kalia YN, Guy RH. Post-iontophoresis recovery of human skin impedance in vivo. Eur J Pharm Biopharm. 2002;53:15–21.
   PubMed Web of Science ®Google Scholar
• Kalia YN, Nonato LB, Guy RH. The effect of iontophoresis on skin barrier integrity: non-invasive evaluation by impedance spectroscopy and transepidermal water loss. Pharm Res. 1996;13:957–960.
   PubMed Web of Science ®Google Scholar
• Gratieri T, Kalaria D, Kalia YN. Non-invasive iontophoretic delivery of peptides and proteins across the skin. Expert Opin Drug Deliv. 2011;8:645–663.
   PubMed Web of Science ®Google Scholar
• Tomoda K, Watanabe A, Suzuki K, et al. Enhanced transdermal permeability of estradiol using combination of PLGA nanoparticles system and iontophoresis. Colloids Surf B Biointerfaces. 2012;97:84–89.
   PubMed Web of Science ®Google Scholar
• Liu W, Hu M, Liu W, et al. Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetate. Int J Pharm. 2008;364:135–141.
   PubMed Web of Science ®Google Scholar
• Kalaria DR, Patel P, Merino V, et al. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo. Eur J Pharm Biopharm. 2014;88:56–63.
   PubMed Web of Science ®Google Scholar
• Ledger PW. Skin biological issues in electrically enhanced transdermal delivery. Adv Drug Deliv Rev. 1992;9:289–307.
   Web of Science ®Google Scholar
• Tari K, Khamoushian S, Madrakian T, et al. Controlled transdermal iontophoresis of insulin from water-soluble polypyrrole nanoparticles: an in vitro study. Int J Mol Sci. 2021;22:12479.
   PubMed Web of Science ®Google Scholar
• Pikal MJ. The role of electroosmotic flow in transdermal iontophoresis. Adv Drug Deliv Rev. 2001;46:281–305.
   PubMed Web of Science ®Google Scholar
• Pikal MJ. Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes. Pharm Res. 1990;07:118–126.
   Google Scholar
• Pikal MJ, Shah S. Transport mechanisms in iontophoresis. II. electroosmotic flow and transference number measurements for hairless mouse skin. Pharm Res. 1990;07:213–221.
   Google Scholar
• Pikal MJ, Shah S. Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes. Pharm Res. 1990;07:222–229.
   Google Scholar
• Takeuchi I, Takeshita T, Suzuki T, et al. Iontophoretic transdermal delivery using chitosan-coated PLGA nanoparticles for positively charged drugs. Colloids Surf B Biointerfaces. 2017;160:520–526.
   PubMed Web of Science ®Google Scholar
• Takeuchi I, Suzuki T, Makino K. Iontophoretic transdermal delivery using chitosan-coated PLGA nanoparticles for transcutaneous immunization. Colloids Surf Physicochem Eng Asp. 2021;608:125607.
   Web of Science ®Google Scholar
• Toyoda M, Hama S, Ikeda Y, et al. Anti-cancer vaccination by transdermal delivery of antigen peptide-loaded nanogels via iontophoresis. Int J Pharm. 2015;483:110–114.
   PubMed Web of Science ®Google Scholar
• Danhier F, Ansorena E, Silva JM, et al. PLGA-based nanoparticles: an overview of biomedical applications. J Controlled Release. 2012;161:505–522.
   PubMed Web of Science ®Google Scholar
• Tomoda K, Terashima H, Suzuki K, et al. Enhanced transdermal delivery of indomethacin-loaded PLGA nanoparticles by iontophoresis. Colloids Surf B Biointerfaces. 2011;88:706–710.
   PubMed Web of Science ®Google Scholar
• Tomoda K, Terashima H, Suzuki K, et al. Enhanced transdermal delivery of indomethacin using combination of PLGA nanoparticles and iontophoresis in vivo. Colloids Surf B Biointerfaces. 2012;92:50–54.
   PubMed Web of Science ®Google Scholar
• Takeuchi I, Fukuda K, Kobayashi S, et al. Transdermal delivery of estradiol-loaded PLGA nanoparticles using iontophoresis for treatment of osteoporosis. Biomed Mater Eng. 2016;27:475–483.
   PubMed Web of Science ®Google Scholar
• Takeuchi I, Kobayashi S, Hida Y, et al. Estradiol-loaded PLGA nanoparticles for improving low bone mineral density of cancellous bone caused by osteoporosis: application of enhanced charged nanoparticles with iontophoresis. Colloids Surf B Biointerfaces. 2017;155:35–40.
   PubMed Web of Science ®Google Scholar
• Takeuchi I, Suzuki T, Makino K. Skin permeability and transdermal delivery route of 50-nm indomethacin-loaded PLGA nanoparticles. Colloids Surf B Biointerfaces. 2017;159:312–317.
   PubMed Web of Science ®Google Scholar
• Takeuchi I, Hidaka Y, Oshizaka T, et al. Chitosan-coated PLGA nanoparticles for transcutaneous immunization: skin distribution in lysozyme-sensitized mice. Colloids Surf B Biointerfaces. 2022;220:112916.
   PubMed Web of Science ®Google Scholar
• Malinovskaja-Gomez K, Labouta HI, Schneider M, et al. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles. Eur J Pharm Sci. 2016;89:154–162.
   PubMed Web of Science ®Google Scholar
• Shiota K, Hama S, Yoshitomi T, et al. Prevention of UV-Induced melanin production by accumulation of redox nanoparticles in the epidermal layer via iontophoresis. Biol Pharm Bull. 2017;40:941–944.
   PubMed Web of Science ®Google Scholar
• Essa EA, Bonner MC, Barry BW. Electrically assisted skin delivery of liposomal estradiol; phospholipid as damage retardant. J Controlled Release. 2004;95:535–546.
   PubMed Web of Science ®Google Scholar
• Malinovskaja-Gomez K, Espuelas S, Garrido MJ, et al. Comparison of liposomal drug formulations for transdermal iontophoretic drug delivery. Eur J Pharm Sci. 2017;106:294–301.
   PubMed Web of Science ®Google Scholar
• Petrilli R, Eloy JO, Saggioro FP, et al. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection. J Controlled Release. 2018;283:151–162.
   PubMed Web of Science ®Google Scholar
• Kigasawa K, Miyashita M, Kajimoto K, et al. Efficient intradermal delivery of superoxide dismutase using a combination of liposomes and iontophoresis for protection against UV-Induced skin damage. Biol Pharm Bull. 2012;35:781–785.
   PubMed Web of Science ®Google Scholar
• Moura RBP, Andrade LM, Alonso L, et al. Combination of lipid nanoparticles and iontophoresis for enhanced lopinavir skin permeation: impact of electric current on lipid dynamics. Eur J Pharm Sci. 2022;168:106048. DOI:10.1016/j.ejps.2021.106048
   PubMed Web of Science ®Google Scholar
• Charoenputtakun P, Li SK, Ngawhirunpat T. Iontophoretic delivery of lipophilic and hydrophilic drugs from lipid nanoparticles across human skin. Int J Pharm. 2015;495:318–328.
   PubMed Web of Science ®Google Scholar
• Fang C-L, Aljuffali IA, Y-C L, et al. Delivery and targeting of nanoparticles into hair follicles. Ther Deliv. 2014;5:991–1006.
   PubMedGoogle Scholar
• Andrade LM, de Fátima Reis C, Maione-Silva L, et al. Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles. Eur J Pharm Biopharm. 2014;88:40–47.
   PubMed Web of Science ®Google Scholar
• Camera E, Ludovici M, Galante M, et al. Comprehensive analysis of the major lipid classes in sebum by rapid resolution high-performance liquid chromatography and electrospray mass spectrometry. J Lipid Res. 2010;51:3377–3388.
   PubMed Web of Science ®Google Scholar
• Lademann J, Knorr F, Richter H, et al. Hair follicles as a target structure for nanoparticles. J Innov Opt Health Sci. 2015;08:1530004.
   Google Scholar
• Patzelt A, Richter H, Knorr F, et al. Selective follicular targeting by modification of the particle sizes. J Controlled Release. 2011;150:45–48.
   PubMed Web of Science ®Google Scholar
• Xiang H, Xu S, Zhang W, et al. Skin permeation of curcumin nanocrystals: effect of particle size, delivery vehicles, and permeation enhancer. Colloids Surf B Biointerfaces. 2023;224:113203.
   PubMed Web of Science ®Google Scholar
• Martins Andrade JF, da Cunha Miranda T, Cunha-Filho M, et al. Iontophoresis application for drug delivery in high resistivity membranes: nails and teeth. Drug Deliv Transl Res. 2022 [cited 2022 Nov 2];13(5):1272–1287. DOI:10.1007/s13346-022-01244-0
   PubMed Web of Science ®Google Scholar
• Mutalik S, Parekh HS, Anissimov YG, et al. Iontophoresis-mediated transdermal permeation of peptide dendrimers across human epidermis. Skin Pharmacol Physiol. 2013;26:127–138. DOI:10.1159/000348469
   PubMed Web of Science ®Google Scholar
• Hegde AR, Rewatkar PV, Manikkath J, et al. Peptide dendrimer-conjugates of ketoprofen: synthesis and ex vivo and in vivo evaluations of passive diffusion, sonophoresis and iontophoresis for skin delivery. Eur J Pharm Sci. 2017;102:237–249.
   PubMed Web of Science ®Google Scholar
• Bernardi DS, Bitencourt C, da Silveira DSC, et al. Effective transcutaneous immunization using a combination of iontophoresis and nanoparticles. Nanomed Nanotechnol Biol Med. 2016;12:2439–2448.
   PubMed Web of Science ®Google Scholar
• Labala S, Mandapalli PK, Kurumaddali A, et al. Layer-by-layer polymer coated gold nanoparticles for topical delivery of imatinib mesylate to treat melanoma. Mol Pharm. 2015;12:878–888.
   PubMed Web of Science ®Google Scholar
• Labala S, Jose A, Venuganti VVK. Transcutaneous iontophoretic delivery of STAT3 siRNA using layer-by-layer chitosan coated gold nanoparticles to treat melanoma. Colloids Surf B Biointerfaces. 2016;146:188–197.
   PubMed Web of Science ®Google Scholar
• Gratieri T, Kalia YN Iontophoresis in penetration enhancement. Percutaneous Absorpt [Internet]. 5th ed. Boca Raton: CRC Press; 2021 [cited 2023 Feb 10]. p. 667–686. Available from: https://www.taylorfrancis.com/books/9780429202971/chapters/10.1201/9780429202971-46.
   Google Scholar
• Dubey S, Kalia YN. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough. J Controlled Release. 2014;183:35–42.
   PubMed Web of Science ®Google Scholar
• Gratieri T, Zarhloule R, Dubey S, et al. The influence of skin barrier impairment on the iontophoretic transport of low and high molecular weight permeants. Int J Pharm. 2021;602:120607. DOI:10.1016/j.ijpharm.2021.120607
   PubMedGoogle Scholar